Trials / Completed
CompletedNCT02462720
COMFORT: A Multicenter, Open-label, Randomized, Crossover Study
Multicenter Study to Evaluate Pain Following Treatment of Varicose Vein With Varithena® Compared to Radiofrequency Ablation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate pain the patient experienced following treatment of varicose veins with Varithena® compared to radiofrequency ablation.
Detailed description
A study that evaluates pain following treatment of varicose veins in patients treated with Varithena® and those treated with RFA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varithena® | Varithena® treatment in accordance with full prescribing information and instructions for use |
| DEVICE | Radiofrequency ablation | Radiofrequency ablation conducted per physicians' standard of care. |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-12-01
- Completion
- 2016-03-01
- First posted
- 2015-06-04
- Last updated
- 2021-04-21
- Results posted
- 2018-01-23
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02462720. Inclusion in this directory is not an endorsement.